High doses of radiation also in peripheral procedures

Original title: Patient radiation exposure during percutaneous endovascular revascularization of the lower extremity. Reference: Einat Segal et al. Journal of Vascular Surgery. Article in press.

Percutaneous endovascular revascularization is emerging as the first line treatment for peripheral artery disease for both intermittent claudication and chronic critical limb ischemia. Radiation doses for these interventions, usually prolonged, have not been well documented.

This retrospective study evaluated all lower extremity angioplasty procedures between 2006 and 2011 in a single center. Fluoroscopy time and dose area product (DAP) were registered. 382 procedures in 313 patients receiving lower extremity revascularization were included; a significantly higher DAP was observed in the primitive or the external iliac arteries compared to those performed in femoropopliteal (179.6 vs 63.2 Gy/cm2; p

The contraleteral access resulted in a in a higher DAP than the antegrade access (112.2 vs 42.6 Gy/cm2; p < 0.0001). In a multivariable analysis, the anatomical location of lesions presented the strongest association with radiation dose (p

Conclusion:

Revascularization procedures on lower extremities involve substantial radiation doses that can be compared, on average, with abdomen and pelvis CT scans. Pelvis procedures involve higher doses than those performed in femoropopliteal or infrapatellar territories.

 Editorial Comment:

Radiation doses should be taken into account especially in recanalization procedures of iliac arteries. For femoral or intrapatellar procedures, the antegrade access should be preferred whenever possible. Both the technical difficulty of puncture and the greater chance of complications should be counterbalanced with greater support, a stronger drive and now also lower radiation doses.

SOLACI.ORG

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...